1001TiPA phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer. (23rd October 2018) - Wahner Hendrickson, A E; Costello, B; Jewell, A; Kennedy, V; Fleming, G; Corr, B; Taylor, S E; Lea, J; Reid, J; Swisher, E; Satele, D; Allred, J; et al.